BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34913590)

  • 21. Solitary Adult Rib Langerhans Cell Histiocytosis Evaluated by 18F-FDG PET/CT.
    Wang Q; Yang S; Tang W; Liu H; Chen Y
    Clin Nucl Med; 2021 Sep; 46(9):756-758. PubMed ID: 33795592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET-CT in pediatric Langerhans cell histiocytosis.
    Kaste SC; Rodriguez-Galindo C; McCarville ME; Shulkin BL
    Pediatr Radiol; 2007 Jul; 37(7):615-22. PubMed ID: 17564738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET/CT Imaging for Langerhans Cell Histiocytosis Involving Only Posterior Elements of the Cervical Vertebra.
    Zhang W; Xie H; Su M
    Clin Nucl Med; 2021 Nov; 46(11):e531-e533. PubMed ID: 34606487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive Langerhans cell histiocytosis transformation of T cell acute lymphoblastic leukemia detected on
    Wang J; Song T; Wang J; Ma L; Jiang Y; Kong D; Zhang B; Lu J
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):642-643. PubMed ID: 32504290
    [No Abstract]   [Full Text] [Related]  

  • 25. Pituitary involvement of langerhans cell histiocytosis in an adult unveiled by FDG PET/CT.
    Ju H; Pan Y; Lv J; Mao X; Zhang Y
    Clin Nucl Med; 2015 Jun; 40(6):509-11. PubMed ID: 25546208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary langerhans cell histiocytosis: PET/CT for initial workup and treatment response evaluation.
    Hansen NJ; Hankins JH
    Clin Nucl Med; 2015 Feb; 40(2):153-5. PubMed ID: 24999688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F-18 FDG PET/CT imaging of solitary liver Langerhans cell histiocytosis: preliminary findings.
    Hu X; Dong A; Lv S; Wang Q; Zhan X; Song X; Wang J
    Ann Nucl Med; 2012 Jun; 26(5):436-9. PubMed ID: 22396242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
    Lee HJ; Ahn BC; Lee SW; Lee J
    Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comment on: FDG PET-CT in pediatric Langerhans cell histiocytosis: Can all birds be killed with just one stone?
    Buhtoiarov IN
    Pediatr Blood Cancer; 2020 May; 67(5):e28214. PubMed ID: 32037736
    [No Abstract]   [Full Text] [Related]  

  • 30. Langerhans cell histiocytosis of the auditory canal detected by 18F-FDG PET/CT.
    Mueller RJ; Siegel A; Seltzer M; McKnight TA
    Clin Nucl Med; 2012 Sep; 37(9):908-9. PubMed ID: 22889788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ¹⁸F-FDG PET/CT in worsening of Primary Sclerosing Cholangitis concomitant with improved Langerhans Cell Histiocytosis.
    Jain S; Karunanithi S; Singla S; Kumar A; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):386-7. PubMed ID: 25043775
    [No Abstract]   [Full Text] [Related]  

  • 32. FDG-PET/CT in pulmonary and cardiac Langerhans' cell histiocytosis and metastatic non-small cell lung cancer.
    Schreiber J; Waldburg N
    Nucl Med Biol; 2012 Nov; 39(8):1173-4. PubMed ID: 22819194
    [No Abstract]   [Full Text] [Related]  

  • 33. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma.
    Szturz P; Řehák Z; Koukalová R; Adam Z; Krejčí M; Pour L; Zahradová L; Vaníček J; Nebeský T; Hájek R; Mayer J
    Nucl Med Biol; 2012 Apr; 39(3):429-36. PubMed ID: 22172385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of
    Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
    Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
    Verghote F; Poppe L; Verbeke S; Dirix P; Albersen M; De Meerleer G; Berghen C; Ost P; Villeirs G; De Visschere P; De Man K; De Maeseneer D; Rottey S; Van Praet C; Decaestecker K; Fonteyne V
    BMC Cancer; 2021 Oct; 21(1):1113. PubMed ID: 34663254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings.
    Binkovitz LA; Olshefski RS; Adler BH
    Pediatr Radiol; 2003 Sep; 33(9):598-602. PubMed ID: 12879314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.